CDEK
← All organizations

Quotient

For profitWebsite ↗

Also known as: QS Pharma | Quotient Bioresearch | Quotient Bioresearch Clinical Services | Quotient Bioresearch Ltd | Quotient Clinical | Quotient Clinical Limited | Quotient Clinical Ltd | Quotient Clinical LTD | Quotient Clinical Ltd, Mere Way, Ruddington Fields, Nottingham, United Kingdom. NG11 6JS | Quotient Clinical Ltd, United Kingdom | Quotient Clinical Mere Way Ruddington Fields Ruddington Nottingham NG11 6JS, UK | Quotient Clinical, Mere Way, Ruddington Fields, Ruddington, Nottinham NG11 6JS, UK | Quotient Clinical, Mere Way, Ruddlington Fields, Nottingham | Quotient Clinical Research | Quotient Clinical Unit | Quotient Sciences | Quotient Sciences Limited (indemnified by | Quotient Sciences Limited (indemnified by Medical Protection Society) | Quotient Sciences Mere Way Ruddington Fields Ruddington Nottingham NG11 6JS, UK | Quotient Sciences - Miami, Inc. | Quotient Sciences Miami Inc | Quotient Sciences Miami Inc. | Quotient Sciences - Nottingham, UK | Quotient Sciences Nottingham, UK, NG116JS | Quotient Sciences Principal Investigator | Senior Medical Director, Quotient Sciences

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Feb 1, 2010

Last known activity

Nov 10, 2025

Acquired by Pharmaron on Feb 4, 2016

Timeline

1990s

  1. Jan 1, 1990

    Quotient— Founded

2000s

  1. Dec 16, 2008

    Pharmaceutical Profiles— Acquired

2010s

  1. Dec 16, 2015

    Co-Formulate Ltd.— Acquired

  2. Feb 4, 2016

    Pharmaron— Acquired By

  3. Feb 6, 2017

    SeaView Research— Acquired

  4. Nov 13, 2017

    PharMaterials Ltd.— Acquired

2020s

  1. Feb 11, 2021

    Arcinova— Acquired

Drugs by trial phase (170 distinct, 163 trials)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (5 direct, 5 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Nottingham, GB Jan 1, 1990
Last known activity
Nov 10, 2025

Notes

In US and UK (6 locations total)